Last Posted: Jun 29, 2018
- Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer.
Murali Rajmohan et al. Journal of the National Comprehensive Cancer Network : JNCCN 2018 Feb (2) 201-209 - The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
McAlpine Jessica et al. The Journal of pathology 2018 Apr (5) 538-549 - Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD).
Leenders Erika K S M et al. European journal of human genetics : EJHG 2018 Jun - The practice of universal screening for Lynch syndrome in newly diagnosed endometrial carcinoma
A Wang et al, Health Services Reports, June 2018 - A Pap-Based Test to Detect Endometrial and Ovarian Cancers Early.
Abbasi Jennifer et al. JAMA 2018 May 319(18) 1853 - Biotech Firm Takes The First Steps In Its Quest For A Blood Test For Cancer
M Herper, Forbes, June 2, 2018 - Endometrial cancer: Molecular markers and management of advanced stage disease.
Arend Rebecca C et al. Gynecologic oncology 2018 May - Genomic Markers Can Predict the Presence of Lynch Syndrome across a Broad Spectrum of Cancers
MSKCC, June 2, 2018 - MSI-H Status May Predict Lynch Syndrome Across Varied Tumor Types
ASCO Daily News, June 4, 2018 - Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
Yokoyama Takanori et al. BMC cancer 2018 May 18(1) 576
.jpg)
No hay comentarios:
Publicar un comentario